AstraZenica, bio firm BioKangtai agree to produce COVID-19 vaccine for China
Thursday, August 6, 2020 - 09:30
in Mathematics & Economics
British drugmaker AstraZeneca said Thursday it has an agreement with a Chinese company to produce 100 million doses of its COVID-19 vaccine, when completed, in China by the end of this year.